WASHINGTON, Jan. 17, 2018 /PRNewswire-USNewswire/ -- LUNGevity has issueda Request for Applications (RFA) for translational research for Career Development Awards that will be granted in 2018. The RFA is available on the LUNGevity website at http://www.LUNGevity.org/CDA-RFA and is also posted on the proposalCENTRAL website
LUNGevity's Career Development Awards for Translational Research program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas.
Successful applicants may receive $100,000 per year for a possible period of three years and will participate as non-voting members of LUNGevity's Scientific Advisory Board for the duration of the award.
Applicants must be within the first five years of their first faculty appointment. The Career Development Awards are mentored awards, and a mentoring plan is part of the required submission. "Our Career Development Award Program is in its seventh year, and we are excited to solicit yet another round of high-quality research proposals from the next generation of lung cancer researchers. Past awardees have already gone on to become independent investigators conducting impactful research focused on improving the outcomes for people living with lung cancer," noted Dr. Upal Basu Roy, Director of LUNGevity's Translational Science Research Program.
Projects that will be funded in 2018 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.
Letters of intent must be submitted by Tuesday, February 20, 2018.
LUNGevity supports the largest research awards program of any lung cancer-focused organization in the United States. Since 2002, LUNGevity has funded 121 projects at 58 institutions in 23 states.
About LUNGevity Foundation
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, please visit www.LUNGevity.org.
View original content:http://www.prnewswire.com/news-releases/lungevity-foundation-issues-request-for-applications-for-2018-career-development-awards-for-translational-research-in-lung-cancer-300583959.html
SOURCE LUNGevity Foundation
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All